Fucikova, J., Truxova, I., Hensler, M., Becht, E., Kasikova, L., Moserova, I., . . . Spisek, R. (2016). Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood.
Čikaški stil citiranjaFucikova, Jitka, et al. "Calreticulin Exposure By Malignant Blasts Correlates With Robust Anticancer Immunity and Improved Clinical Outcome in AML Patients." Blood 2016.
MLA način citiranjaFucikova, Jitka, et al. "Calreticulin Exposure By Malignant Blasts Correlates With Robust Anticancer Immunity and Improved Clinical Outcome in AML Patients." Blood 2016.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.